These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25029906

  • 1. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
    Anticancer Res; 2017 Jun 25; 37(6):3129-3135. PubMed ID: 28551654
    [Abstract] [Full Text] [Related]

  • 4. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z.
    Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H.
    Diagn Pathol; 2015 Jul 28; 10():128. PubMed ID: 26215716
    [Abstract] [Full Text] [Related]

  • 7. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
    Huang L, Xu AM, Peng Q.
    Int J Clin Exp Pathol; 2015 Jul 28; 8(2):1929-37. PubMed ID: 25973085
    [Abstract] [Full Text] [Related]

  • 8. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.
    Ayed-Guerfali DB, Hassairi B, Khabir A, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R.
    Tumour Biol; 2014 Mar 28; 35(3):1775-83. PubMed ID: 24197976
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M, Yamashita H, Watanabe T, Seto Y.
    World J Surg; 2018 Jan 28; 42(1):185-194. PubMed ID: 28741195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    Chen L, Jin T, Fang Y, Wu G, Yuan Y.
    J Gastroenterol Hepatol; 2024 Jun 28; 39(6):1073-1081. PubMed ID: 38353050
    [Abstract] [Full Text] [Related]

  • 13. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
    Han WX, Chen ZM, Wei ZJ, Xu AM.
    World J Surg Oncol; 2016 Nov 03; 14(1):279. PubMed ID: 27809860
    [Abstract] [Full Text] [Related]

  • 14. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
    Chen L, Tang K, Wang S, Chen D, Ding K.
    Cancer Control; 2021 Nov 03; 28():10732748211026668. PubMed ID: 34155922
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb 03; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction.
    Ma RJ, Zheng QM, Zhang N, Sun ZG.
    Dis Markers; 2022 Feb 03; 2022():9311684. PubMed ID: 36225196
    [Abstract] [Full Text] [Related]

  • 17. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
    Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM.
    World J Gastroenterol; 2002 Dec 03; 8(6):987-93. PubMed ID: 12439911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH.
    Medicine (Baltimore); 2016 May 03; 95(21):e3473. PubMed ID: 27227913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.